<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Medications that interfere with the effect of warfarin</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Medications that interfere with the effect of warfarin</h1>
<div class="graphic"><div class="figure"><div class="ttl">Medications that interfere with the effect of warfarin</div><div class="cntnt"><table cellspacing="0" class="container"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="container"> <table cellspacing="0"> <tbody> <tr> <td class="subtitle1_single">May increase INR</td> </tr> <tr> <td class="indent1">Acetaminophen</td> </tr> <tr> <td class="indent1">Allopurinol</td> </tr> <tr> <td class="indent1">Amiodarone</td> </tr> <tr> <td class="indent1">Androgens <ul class="decimal_heading"> <li>Methyltestosterone</li> <li>Oxandrolone</li> <li>Testosterone</li> </ul> </td> </tr> <tr> <td class="indent1">Antibiotics <ul class="decimal_heading"> <li>Cephalosporins</li> <li>Doxycycline</li> <li>Fluoroquinolones <ul> <li>Ciprofloxacin</li> <li>Levofloxacin</li> <li>Moxifloxacin</li> <li>Norfloxacin</li> </ul> </li> <li>Macrolides <ul> <li>Azithromycin</li> <li>Clarithromycin</li> <li>Erythromycin</li> </ul> </li> <li>Metronidazole</li> <li>Penicillins (<strong>exceptions:</strong> dicloxacillin and nafcillin may decrease the INR) <ul> <li>Amoxicillin</li> <li>Amoxicillin-clavulanate</li> </ul> </li> <li>Trimethoprim-sulfamethoxazole</li> </ul> </td> </tr> <tr> <td class="indent1">Azole antifungals* <ul class="decimal_heading"> <li>Fluconazole</li> <li>Miconazole (oral)</li> <li>Voriconazole</li> </ul> </td> </tr> <tr> <td class="indent1">Cancer therapies <ul class="decimal_heading"> <li>Capecitabine</li> <li>Fluorouracil (5-FU)</li> <li>Imatinib</li> <li>Tamoxifen</li> </ul> </td> </tr> <tr> <td class="indent1">Cholesterol-lowering agents (<strong>exception:</strong> cholestyramine may decrease the INR) <ul class="decimal_heading"> <li>Fenofibrate</li> <li>Fluvastatin</li> <li>Gemfibrozil</li> <li>Lovastatin</li> <li>Rosuvastatin</li> <li>Simvastatin</li> </ul> </td> </tr> <tr> <td class="indent1">Cimetidine</td> </tr> <tr> <td class="indent1">Glucocorticoids <ul class="decimal_heading"> <li>Methylprednisolone</li> <li>Prednisone</li> </ul> </td> </tr> <tr> <td class="indent1">Omeprazole (case reports with other proton pump inhibitors)</td> </tr> <tr> <td class="indent1">Serotonin reuptake inhibitors<sup>¶</sup> <ul class="decimal_heading"> <li>Duloxetine</li> <li>Fluoxetine</li> <li>Fluvoxamine</li> <li>Venlafaxine</li> </ul> </td> </tr> <tr> <td class="indent1">Sitaxentan (not available in United States)</td> </tr> <tr> <td class="indent1">Tramadol</td> </tr> </tbody> </table> </td> <td class="container"> <table cellspacing="0"> <tbody> <tr> <td class="subtitle1_single">May decrease INR</td> </tr> <tr> <td class="indent1">Antibiotics <ul class="decimal_heading"> <li>Dicloxacillin</li> <li>Griseofulvin</li> <li>Nafcillin</li> <li>Rifampin</li> </ul> </td> </tr> <tr> <td class="indent1">Azathioprine</td> </tr> <tr> <td class="indent1">Cholestyramine</td> </tr> <tr> <td class="indent1">Enzyme-inducing antiseizure medications <ul class="decimal_heading"> <li>Carbamazepine</li> <li>Phenobarbital</li> <li>Phenytoin (mixed effects described)</li> </ul> </td> </tr> <tr> <td class="indent1">Ritonavir</td> </tr> <tr> <td class="indent1">Saint John's wort</td> </tr> <tr> <td class="indent1">Sucralfate</td> </tr> <tr> <td class="indent1">Vitamin K</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This is a partial list of medications that may increase or decrease warfarin effect on the INR. The patient's medications should be analyzed closely for drug interactions with warfarin, especially when initiating or altering therapy. The effect of a drug interaction can be unpredictable; thus, individuals receiving interacting medications are likely to require increased INR monitoring. Additional medications may increase bleeding risk independent of (or in addition to) effects on the INR (eg, NSAIDs, antiplatelet medications). Refer to UpToDate for additional details. Drug interactions may be evaluated using the Lexi-interact program included with UpToDate.</div><div class="graphic_footnotes"><p>INR: international normalized ratio; NSAIDs: nonsteroidal anti-inflammatory drugs.</p>
<p>* A more moderate effect on INR control may also be seen with posaconazole and itraconazole.</p>
¶ In addition to potentially increasing the INR, serotonin reuptake inhibitors may also increase bleeding risk by inhibiting platelet reuptake of serotonin.</div><div class="graphic_reference">References:
<ol>
<li>Greenblatt DJ, von Moltke L. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol 2005; 45:127.</li>
<li>Holbrook A, Schulman S, Witt D, et al. Evidenced-based management of anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed. Chest 2012; 141:e152S.</li>
<li>Hazlewood KA, Fugate SE, Harrison DL. Effect of oral corticosteroids on chronic warfarin therapy. Ann Pharmacother 2006; 40:2101.</li>
<li>Lexi-Interact. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</li>
</ol></div><div id="graphicVersion">Graphic 62697 Version 16.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
